| Barron, Hal (GSK 201801– CSO before Alphabet (Calicio) + Roche/Genentech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GSK (Group) |
United Kingdom (GB) |
| Debruyne, Luc (GSK 201504 President of GSK Vaccines) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
Belgium |
| Diaz, Allene M. (Tesaro 201609 SVP Global Commerical Developm before Merck Serono + Biogen Idec + Pfizer) |
Chief Commercial Officer (CCO) |
GSK (Group) |
United States (USA) |
| Dilly, Stephen (Sierra Oncology 202204 CEO formerly Aimmune Therapeutics 201611–201806 CEO + Chiron BioPharma) |
Chief Executive Officer (CEO) |
GSK (Group) |
United States (USA) |
| Edwards, Tim (Cellzome 200507 CEO) |
Board member, non-executive |
GSK (Group) |
Germany |
| Garnier, Jean-Pierre (Pierre Fabre Labs 2008–2010 CEO before GSK 2001–2008 CEO before SmithKline Beecham CEO) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
| Hanke, Jeffrey (Jeff) (Tesaor 201506– CSO before Boehringer + AstraZeneca + Pfizer) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
GSK (Group) |
United States (USA) |
| Hardenbicker, Markus (GSK 201703 Head Corporate Communications at GlaxoSmithKline GmbH & Co KG) |
Public Relations Manager / Investor Relations Manager |
GSK (Group) |
Germany |
| Husslein, Volker (GSK 201703 Head Communications at GSK Vaccines GmbH) |
Public Relations Manager / Investor Relations Manager |
GSK (Group) |
Germany |
| Martinez-Davis, Maya (GSK 202001– President of GSK US Pharma joined 9/19 before Merck (DE) + Pfizer) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
United Kingdom (GB) |
| McNamara, Brian (GSK 201609– CEO of Consumer Healthcare division before Novartis + Procter & Gamble) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
| Miels, Luke (GSK 201701– President Global Pharma before AstraZeneca + Roche + Sanofi-Aventis) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
United Kingdom (GB) |
| Neubauer, Gitte (Cellzome 2000 Founder) |
Company Founder |
GSK (Group) |
Germany |
| Rappuoli, Rino (GSK 202110 Head of Vaccines RnD) |
Research & Development Manager |
GSK (Group) |
United Kingdom (GB) |
| Ratcliffe, Andrew (Cellzome 200809– Director Chemistry before UCB Celltech) |
n. a. |
GSK (Group) |
United States (USA) |
| Redfern, David (GSK 201508 Chief Strategy Officer) |
Corporate Strategy Manager |
GSK (Group) |
United Kingdom (GB) |
| Reutter, Jochen (GSK 201703 Managing Director GSK Vacccines GmbH) |
Managing Director |
GSK (Group) |
Germany |
| Shannon, James S. (GSK 201205– CMO before Board Member several firms before 14y at Novartis until 2008) |
Chief Medical Officer (CMO) |
GSK (Group) |
United Kingdom (GB) |
| Slaoui, Moncef (GSK –201707 Chairman Vaccines TO RETIRE 6/17) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
United Kingdom (GB) |
| Stéphenne, Jean (GSK Biologicals 200512 President) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
Belgium |
| Sykes, Richard (Glaxo-Wellcome) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
| Werner, Thomas (Board Member of several companies before GSK SVP) |
Board member, non-executive |
GSK (Group) |
United Kingdom (GB) |
| Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head) |
Chief Executive Officer (CEO) |
GSK (Group) |
United Kingdom (GB) |
| Bingler, Dirk (GUS Group 201706 Managing Director of GUS Deutschland GmbH) |
Managing Director |
GUS Group (Group) |
Germany |
| Korn, Lothar (Analytik Jena 201101 Managing Director AJ Blomesystem GmbH + Comicon GmbH) |
Managing Director |
GUS Group (Group) |
Germany |
| Cunningham, Craig (Maine Manufacturing 2007– Founder + VP Engineering + Development) |
Research & Development Manager |
GVS (IT) (Group) |
United States (USA) |
| Beier, Cornelia (Leon-Nanodrugs 201010– Managing Director + Co-Founder) |
Managing Director |
H.A.C. Pharma (FR) |
Germany |
| Beier, Wolfgang (Leon-Nanodrugs 201010– Medical Director + Co-Founder) |
Chief Medical Officer (CMO) |
H.A.C. Pharma (FR) |
Germany |
| Frickel, Hans (Leon-Nanodrugs 202307– CEO before R-Biopharm + BioNTech + Evonik + Midas Pharma P&G + Merck) |
Chief Executive Officer (CEO) |
H.A.C. Pharma (FR) |
Germany |
| Tinko-Kuhar, Maja (Leon-Nanodrugs 202307 Marketing Manager) |
Sales Manager / Marketing Manager |
H.A.C. Pharma (FR) |
Germany |
| Mucke, Hermann (H.M. Pharma Consultancy) |
Consultant (economic/technology) |
H.M. Pharma Consultancy [Hermann Mucke Pharma Consultancy e.U.] |
Austria |
| Akay, Ingrid Teigland (Hadean Ventures 201604 Managing Director) |
Managing Director |
Hadean Ventures AS |
Norway |
| Beyer, Ingrid (Hadean Ventures 202110 Head of IR + Business Development) |
Public Relations Manager / Investor Relations Manager |
Hadean Ventures AS |
Norway |
| Franklin, Roger (Hadean Ventures 202007 Partner) |
Partner (venture partner) |
Hadean Ventures AS |
Norway |
| Green, Nicola (Halesway Ltd 201201– Account Director before Alto Marketing 201110 Account Director, Life Science) |
public relations / investor relations |
Halesway Ltd. |
United Kingdom (GB) |
| Kirk, Randal J. (Intrexon 201502 CEO) |
Chief Executive Officer (CEO) |
Halozyme Therapeutics Inc. (Nasdaq: HALO) |
United States (USA) |
| Sinclair, Mike (Halsin Partners 201110 Partner + Co-founder before Burns McClellan) |
Public Relations Manager / Investor Relations Manager |
Halsin Partners Ltd. |
United Kingdom (GB) |
| Mennenga-Klopp, Erk (Hamamatsu 200810 Head Medical Solutions Dept Hamamatsu Germany) |
n. a. |
Hamamatsu (Group) |
Germany |
| Brilling, Julia (Norgenta 201211 Project Manager Industrial Cell Technology) |
Cluster Manager |
Hamburg (govt region) |
Germany |
| Bunge, Dörte (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Fischer, Benjamin (Hamburg (govt) 201707 Program Adivsor Innovation at IFB Hamburg) |
n. a. |
Hamburg (govt region) |
Germany |
| Funk, Lucas (Hamburg (govt) 202101 at Innovationsstarter Fonds Hamburg) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Gelbke, Franz (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
| Gundelach, Herlind (Hamburg (govt) 201004 Economic Minister) |
Minister |
Hamburg (govt region) |
Germany |
| Habeck, Hinrich (Norgenta 201203– Managing Director before Ascenion GmbH + Greiner Bio-One + Artemis) |
Managing Director |
Hamburg (govt region) |
Germany |
| Honold, Maike (Life Science Nord 202312 Director Finance) |
Chief Financial Officer (CFO) |
Hamburg (govt region) |
Germany |
| Horch, Frank (Hamburg (govt) 201404 Senator für Wirtschaft, Verkehr + Innovation) |
Minister |
Hamburg (govt region) |
Germany |
| Huhle, Doreen (Hamburg (govt) 201208 Investment Manager at Innovationsstarter Hamburg GmbH) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Milde, Heiko (Hamburg (govt) 201208 Managing Director of Innovationsstarter Hamburg GmbH) |
Managing Director |
Hamburg (govt region) |
Germany |
| Pavkovic, Damir (Norgenta 201211 Manager Marketing) |
Sales Manager / Marketing Manager |
Hamburg (govt region) |
Germany |
| Sahin, Gencer (Hamburg (govt) 201603 Investment Manager at Innovationsstarter Fonds Hamburg) |
Investment Manager |
Hamburg (govt region) |
Germany |
| Schneemann, Imke (Hamburg (govt) 201202– Head of Norgenta Office in Kiel + project management marine biotech) |
Cluster Manager |
Hamburg (govt region) |
Germany |
| Scholz, Olaf (Hamburg (govt) 201104 Major, SPD) |
Mayor |
Hamburg (govt region) |
Germany |
| Stapelfeldt, Dorothee (Hamburg (govt) 201104 Minister of Science, SPD) |
Minister |
Hamburg (govt region) |
Germany |
| Walkenhorst, Jürgen (Hamburg (govt) 202206–202312 Managing Director of Life Science Nord before PROvendis RESIGNED) |
Cluster Manager |
Hamburg (govt region) |
Germany |
| Westhagemann, Michael (Hamburg (govt) 202010 Senator for Economics) |
Minister |
Hamburg (govt region) |
Germany |
| Willms, Andrea (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
| Wohltmann, Meike (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
| Carrier, Mark (Hamilton 201303 Market Segment Manager at Hamilton Company) |
Product Manager (personnel) |
Hamilton (Group) |
United States (USA) |
| Düchting, Matthias (Hamilton Robotics 200704 International Sales Director) |
Sales Manager / Marketing Manager |
Hamilton (Group) |
Switzerland |
| Jensen, Derek (Hamilton 201303 HPLC product specialist at Hamilton Company) |
Product Manager (personnel) |
Hamilton (Group) |
United States (USA) |
| Katzenberger, Jörg (Hamilton Life Science Robotics 200704) |
n. a. |
Hamilton (Group) |
Switzerland |
| Pochert, Jörg (Hamilton 201608 VP Life Science Robotics at Hamilton Bonadzu) |
President/Director/Head Business Group/Unit/Division |
Hamilton (Group) |
Switzerland |
| Tillich, Dirk (Hamilton Bonaduz 200707 Head Marketing + Sales, Business Unit Analytics) |
Sales Manager / Marketing Manager |
Hamilton (Group) |
Switzerland |
| Thomas, Russell S. (The Hamner Institutes 201112 Director of Institute for Chemical Safety Sciences) |
Researcher (university / research institute) |
Hamner Institutes for Health Sciences, The |
United States (USA) |
| Wagner, Thomas (Hannover Capital 201104 Managing Director) |
Managing Director |
Hannover Capital Partners Management GmbH (HCP) |
Germany |
| Weddrin, Willi (Hannover Capital 201104 Managing Director) |
Managing Director |
Hannover Capital Partners Management GmbH (HCP) |
Germany |
| Kopp, Adolf M. (Hannoverimpuls 2014– Managing Director before TSB Innovationsagentur Berlin before BIA Bremen) |
n. a. |
Hanover (govt city) |
Germany |
| Lerch, Marina (Hannover (govt) 201404 Project Director Health Care Industries) |
Cluster Manager |
Hanover (govt city) |
Germany |
| Tulstrup, Søren (Hansa Biopharma 2018– CEO formerly Galenica + Shire + Santaris Pharma) |
Chief Executive Officer (CEO) |
Hansa Biopharma AB |
Sweden |
| Barten, Jan Alexander (Hansa Fine Chemicals 201212 Managing Director) |
Managing Director |
Hansa Fine Chemicals GmbH |
Germany |
| Przyborowski, Falko (Hansa Fine Chemicals 201212 Managing Director) |
Managing Director |
Hansa Fine Chemicals GmbH |
Germany |
| Sevenard, Dmitry (Hansa Fine Chemicals 201212 Managing Director) |
Managing Director |
Hansa Fine Chemicals GmbH |
Germany |
| Brummelkamp, Thijn (Haplogen 2010– Founder) |
Company Founder |
Haplogen Bioscience GmbH |
Austria |
| Casari, Georg (CeMM 201211 Director + Haplogen 201211 CEO + founder before Oridis Biomed + Cellzome + Lion Bioscience) |
Managing Director |
Haplogen Bioscience GmbH |
Austria |
| Moser, Thomas (Haplogen 201410 CEO) |
Chief Executive Officer (CEO) |
Haplogen Bioscience GmbH |
Austria |
| Boven, Karl-Heinz (Multi Channel Systems MCS Founder) |
Company Founder |
Harvard Bioscience (Group) |
Germany |
| Duchemin, Jeffrey A. (Harvard Bioscience 201410 CEO) |
Chief Executive Officer (CEO) |
Harvard Bioscience (Group) |
United States (USA) |
| Möller, Andreas (Multi Channel Systems MCS Founder) |
Company Founder |
Harvard Bioscience (Group) |
Germany |
| Berlin, Vivian (Harvard Univ 201305 Director Business Developmet at Office of Technology Development) |
Business Development Manager / Strategy Manager |
Harvard University |
United States (USA) |
| Church, George (Harvard Univ Prof) |
Professor |
Harvard University |
United States (USA) |
| Freeman, Gordon (Harvard Univ 202301 at Dana-Farber Cancer Institute + Academic Founder of NextPoint Tx) |
Researcher (university / research institute) |
Harvard University |
United States (USA) |
| Gygi, Steven (Harvard Univ 201003 Associate Professor Harvard Medical School) |
Professor |
Harvard University |
United States (USA) |
| Kikinis, Ron (Harvard Medical School 201404 Prof + Fraunhofer 201405– Director of Fraunhofer MEVIS) |
Professor |
Harvard University |
United States (USA) |
| Maus, Marcela V. (Harvard Univ 201708 Assistant Prof of Medicine at Harvard Medical + Director at MGHCC) |
Professor |
Harvard University |
United States (USA) |
| Rajewsky, Klaus (Harvard Univ 2002– before Univ Cologne) |
n. a. |
Harvard University |
United States (USA) |
| Sato, Vicki (Harvard Univ 2001104 Prof + Atlas Venture Business Adivisor before Vertex President + CSO before Biogen) |
Board member, non-executive |
Harvard University |
United States (USA) |
| Wagner, Gerhard (Harvard Univ 1990– Prof at Harvard Medical School before Univ Michigan + ETHZ) |
Professor |
Harvard University |
United States (USA) |
| Schenkendorf, René (Harz Univ 202109 Professor for Manufacturing/Industry 4.0 before TU Braunschweig) |
Professor |
Harz University of Applied Sciences Wernigerode |
Germany |
| Meinel, Christoph (Hasso Plattner Institute 201211 Director + Prof at Univ Potsdam) |
President/Director/Head Business Group/Unit/Division |
Hasso-Plattner-Institut für Softwaresystemtechnik GmbH (HPI, Hasso Plattner Institute) |
Germany |
| Davidson, Eran (HassoPlattnerVentures 200506 + DBI AG 201508 Supervisory Board Member) |
Investment Manager |
HassoPlattnerVentures Management GmbH |
Germany |
| Plattner, Hasso (SAP founder) |
n. a. |
HassoPlattnerVentures Management GmbH |
Germany |
| Witty, Andrew (Hatteras Venture Partners 201709– Venture Partner former GSK CEO 2008–2017 joined 1985) |
Partner (venture partner) |
Hatteras Venture Partners (HVP) |
United States (USA) |
| Ounzain, Samir (Haya Therapeutics 202105 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Haya Therapeutics S.A. |
Switzerland |
| Beck, Peter (Hölle & Hüttner 200807 Managing Director) |
Managing Director |
HB Technologies (Group) |
Germany |
| Behn, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
| Gausepohl, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
| Hobe, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
| Hüttner, Steffen (Hölle & Hüttner 200807 Managing Director + Founder) |
Managing Director |
HB Technologies (Group) |
Germany |
| Mauch, Herr (Intavis 200809) |
Sales Manager / Marketing Manager |
HB Technologies (Group) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 38 39 40 ... 88 89 90 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
